Journal article

Raloxifene recovers effects of prenatal immune activation on cognitive task-induced gamma power

Anna Schroeder, Jay P Nakamura, Matthew Hudson, Nigel C Jones, Xin Du, Suresh Sundram, Rachel A Hill

Psychoneuroendocrinology | PERGAMON-ELSEVIER SCIENCE LTD | Published : 2019

Abstract

There is currently no treatment available for the cognitive symptoms of schizophrenia, but evidence suggests that selective estrogen receptor modulators (SERMs) may provide relief. Our recent animal model data showed that a lack of female sex hormones in mice impairs the ability of hippocampal neurons to synchronise and generate oscillations within the frequency range of 30-80 Hz (gamma power) leading to cognitive impairment, while both estradiol and the SERM, raloxifene, recovered this. Given that cognitive impairment is accompanied by abnormal gamma power in schizophrenia, this study aimed to determine the effects of raloxifene on gamma power during spatial memory tasks in the prenatal imm..

View full abstract

Grants

Awarded by NARSAD Young Investigator Award from the Brain and Behavior Research Foundation


Awarded by National Health and Medical Research Council (NHMRC) career development award


Funding Acknowledgements

This work was supported by a NARSAD Young Investigator Award from the Brain and Behavior Research Foundation for Dr Rachel Hill (22997) and a National Health and Medical Research Council (NHMRC) career development award for Dr Rachel Hill (1062826). The Behavioural Neuroscience Laboratory are supported by the philanthropic organisation, One in Five.